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Background: We studied potential risk factors for postoperative atrial fibrillation (POAF) in a large cohort of patients
who underwent open-heart surgery, evaluating short- and long-term outcome, and we developed a risk-assessment
model of POAF.
Methods: A retrospective study of 744 patients without prior history of AF who underwent CABG (n = 513), OPCAB
(n = 207), and/or AVR (n = 156) at Landspitali Hospital in 2002–2006. Logistic regression analysis was used to study
risk factors for POAF, comparing patients with and without POAF.
Results: The rate of POAF was 44%, and was higher following AVR (74%) than after CABG (44%) or OPCAB (35%). In
general, patients with POAF were significantly older, were more often female, were less likely to be smokers, had a
lower EF, and had a higher EuroSCORE. The use of antiarrythmics was similar in the groups but patients who
experienced POAF were less likely to be taking statins. POAF patients also had longer hospital stay, higher rates of
complications, and operative mortality (5% vs. 0.7%). In multivariate analysis, AVR (OR 4.4), a preoperative history of
cardiac failure (OR 1.8), higher EuroSCORE (OR 1.1), and advanced age (OR 1.1) were independent prognostic factors
for POAF. Overall five-year survival was 83% and 93% for patients with and without POAF (p <0.001).
Conclusion: POAF was detected in 44% of patients, which is high compared to other studies. In the future, our
assessment score will hopefully be of use in identifying patients at high risk of POAF and lower complications
related to POAF.
Keywords: Postoperative atrial fibrillation, Coronary artery bypass surgery, Atrial valve replacement, Risk factors, Risk
assessment, Prophylaxis, SurvivalBackground
Atrial fibrillation (AF) is common following open-heart
surgery. While postoperative atrial fibrillation (POAF)
can be transient and without consequences, it may lead
to serious complications such as increased risk of acute
kidney injury (AKI), hemodynamic instability, cardiac
failure, stroke, and death [1-3]. As highlighted by the
significantly increased cost of treating patients with this
arrhythmia and its consequences [4], substantial resources
are devoted to detection and treatment of POAF [5,6].
Furthermore, as the rate of POAF increases with age,
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distribution, and reproduction in any mediumpopulation of elderly patients that undergo cardiac
surgery [7,8].
Reported rates of POAF after surgical revascularization
and atrial valve replacement (AVR) range widely, from
3% to 90%, but with most of them in the 20–40% range
[9,10]. This variation is related to different patient popu-
lations, methods and duration of arrhythmia surveillance,
and use of medication for prophylactic purposes. POAF
is most often detected on the second postoperative day
and is frequently self-limiting and short-lived [5]. Up to
80% of patients convert to sinus rhythm (SR) within
24 h, and six weeks after initial diagnosis 98% of patients
have converted to SR [11].
Several risk factors for POAF have been reported,
such as advanced age, genetic predisposition, chronic
obstructive pulmonary disease (COPD), heart failure,
valvular surgery, increased perioperative ischemia, andtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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treatment (e.g. beta-blockers and amiodarone) [13,14]
and non-pharmacological (e.g. atrial pacing) [15-18] have
been used to treat and prevent POAF, but all therapeutic
options have variable efficacy and some may adversely
affect hemodynamic stability.
Identification of patients at high risk of POAF after
cardiac surgery is vital for selection of the patients who
might benefit from intensive prophylactic therapy or
increased monitoring. Thus, an accurate model predict-
ing the risk of POAF might help to define this challen-
ging group preoperatively. We evaluated potential risk
factors for POAF in a large nationwide cohort of patients
who underwent myocardial revascularization with or
without AVR. In addition, we studied short-term compli-
cations, 30-day mortality, and long-term survival.Methods
This was a retrospective whole-population study of all
patients who underwent off-pump coronary artery by-
pass grafting (OPCAB), CABG, and AVR for aortic
stenosis at Landspitali University Hospital in Iceland,
between January 1, 2002 and December 31, 2006. The
hospital is the sole institution performing open-heart
surgery in Iceland and since 1986 over 5,500 open-
heart procedures have been performed.
Patients were identified through two separate registries.
First, a computerized diagnosis and operation registry
was checked for patients who underwent coronary artery
bypass grafting (CABG), OPCAB, and/or AVR with either
biological or mechanical prosthesis. Secondly, a centra-
lized cardiac surgery database at our institution was used
to identify operated patients, thus confirming a 100%
match with the subset identified in the initially men-
tioned registry.
Altogether, 876 patients underwent the surgeries men-
tioned above, representing approximately 87% of all
patients who underwent cardiac surgery in Iceland during
the five-year period. Of these, 207 were OPCAB patients
(24%), 507 underwent CABG (58%), 136 (18%) had aortic
valve surgery, and 20 (2%) had both aortic valve surgery
and coronary revascularization. Altogether, 132 patients
were excluded, most often due to a preoperative history
of AF (n = 109). None of the patients died intraopera-
tively. This left 744 patients for further analysis.
Patients with POAF were compared with patients
with postoperative normal sinus rhythm (NSR). POAF
was defined as AF diagnosed with a rhythm monitor/
telemetry and/or ECG, with duration of ≥ 5 minutes and/
or initiation of treatment for atrial fibrillation such as
amiodarone or cardioversion.
Clinical information was obtained from patient charts
and surgical reports, was registered in a standardizeddata sheet using Excel (Microsoft Corp., Redmond, WA),
and was reviewed by three of the authors (S.H., I.L.I.,
and T.G.). Over 200 variables were registered, includ-
ing gender, age, cardiovascular risk factors, history of
arrhythmia and myocardial infarction. Information on
left ventricular ejection fraction (EF) and medication
was also collected, including anti-arrhythmic drugs
such as beta-blockers, cholesterol-lowering statins, and
anticoagulation or antiplatelet drugs. Patients’ symptoms
were evaluated according to the New York Heart Asso-
ciation classification and their EuroSCORE (European
System for Cardiac Operative Risk Evaluation) calcu-
lated [19]. In addition, information on the degree of
coronary artery disease (i.e. three-vessel disease, left
main stem stenosis), acute vs. elective surgery, cardio-
pulmonary bypass (CPB), cross-clamp time, and skin-
to-skin operative time was registered.
Hospital morbidity was assessed by means of intra-
operative and postoperative complications (minor/major)
and length of stay. Operative mortality was defined as the
number of patients who died within 30 days of surgery.
Apart from AF, postoperative complications were cate-
gorized as either minor or major. Minor complications
included leg wound infection, urinary tract infection,
and pneumonia and major complications stroke, med-
iastinitis, endocarditis, and myocardial infarction (MI)
(defined as isolated ST segment changes or a new left
bundle branch block on ECG along with an elevation of
CK-MB of ≥70 μg/L), AKI as defined by the RIFLE
criteria [20] and necessitating renal replacement therapy,
reoperation, sternum dehiscence, and acute respiratory
distress syndrome (ARDS) or multiple organ failure
(MOF). We also recorded bleeding (defined as the
24-hour postoperative chest tube output) and number
of transfusions of packed red cells (PRC).
Patients were assigned a date and a cause of death or
were identified as still living on September 1, 2010, using
data from the Icelandic National Population Registry.
Overall survival was calculated using the Kaplan-Meier
method. Mean follow-up time was 60 months (range:
0–97 months) and none of the patients were lost to
follow-up.
Statistical methods
Continuous variables were compared between the groups
with t-test or Mann–Whitney test, depending on whether
the data were normally distributed, and categorical vari-
ables were compared using either Fisher’s exact test or
Chi-square test. Survival was plotted on a Kaplan-Meier
curve and the groups were compared with a log-rank
test. A multivariate logistic regression model of inde-
pendent risk factors for POAF was pursued using vari-
ables from the univariate analysis with p-values less than
0.1 as predictor variables, and reducing the model using
Table 1 Comparison of patient demographics for patients with POAF and NSR following CABG/OPCAB±AVR in Iceland
between 2002 and 2006
POAF (n= 326) NSR (n= 418) p-value
Male (%) 244 (74) 349 (83) 0.005
Age in years, mean± SD 70± 9.3 64 ± 8.7 < 0.001
Diabetes (%) 62 (19) 60 (14) 0.11
Hypertension (%) 213 (65) 248 (59) 0.11
Dyslipidemia (%) 161 (49) 263 (63) < 0.001
Smoking history (%) 58 (18) 111 (35) 0.005
Chronic heart failure (%) 66 (20) 35 (8) < 0.001
Mean number of affected vessels 2.4 2.7 < 0.001
Mean left ventricular ejection fraction (LVEF) 51 55 < 0.001
Mean EuroSCORE 6.0 4.0 < 0.001
β blocker use preoperatively (%) 201 (62) 291 (70) 0.074
Ca2+ channel blocker use preoperatively (%) 67 (21) 80 (19) 0.58
Statin use preoperatively (%) 201 (63) 316 (76) < 0.001
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best model was found. The predictive capabilities of the
finalized model were assessed by calculating the area
under the receiver operating characteristic (ROC) curve
and a Cox proportional hazard model assessed the con-
tribution of variables to long-term survival. All variables
in the finalized model met requirements of proportion-
ality. Both odds ratios (ORs) in the logistic models and
hazard ratios (HRs) in the Cox model are reported,
along with 95% confidence intervals. The level of stat-
istical significance was set at p <0.05. All statistical
analysis was performed with R software version 2.12.1
(The R Foundation, Austria) using the survival, MASS,
and pROC packages.
The study was approved by the Icelandic National
Bioethics Committee and the Icelandic Data Protection
Commission. As individual patients were not identified,
obtaining individual consent for the study was waived.Table 2 Comparison of operation-related factors in patients w
Iceland between 2002 and 2006
POAF
CABG/OPCAB (%) 233 (3
AVR (%) 42 (7
AVR+CABG (%) 51 (8
OPCAB (%) 270 (4
Skin-to-skin time in min, mean (range) 205 (9
Time on CPB in min, mean (range) 95 (3
Aortic X-clamp time in min, mean (range) 49 (1
Chest tube bleeding first 24 h in mL, mean (range) 850 (1
Transfusion of PRC in units, median (range) 2 (0
CABG – coronary artery bypass grafting, OPCAB – off-pump coronary artery bypass
packed red cells.Results
The overall incidence of POAF was 44%, and was sig-
nificantly higher in patients who underwent AVR or
combined AVR and CABG compared to those who under-
went myocardial revascularization alone (74%, 81%, and
37%, respectively; p < 0.001). Incidence of POAF was sig-
nificantly lower in patients who underwent OPCAB than
in those who underwent conventional CABG (35% vs.
46%, p = 0.01).
Patient demographics are compared in Table 1. Patients
who experienced POAF were more often female and on
average 6 years older than patients with NSR. They were
more likely to have chronic heart failure but less likely to
have dyslipidemia or a history of smoking. There was no
significant difference between groups regarding diabetes
or hypertension. Significantly fewer coronary vessels were
affected in the POAF group, but their EF was lower and
their EuroSCORE was higher. There was no significantith POAF and NSR following CABG/OPCAB±AVR in
(n = 326) NSR (n= 418) p-value
7) 391 (63) < 0.001
3) 15 (27) < 0.001
1) 12 (19) < 0.001
6) 313 (54) 0.01
0–640) 200 (100–555) < 0.001
8–366) 80 (28–265) < 0.001
9–209) 40 (13–204) < 0.001
20–4,980) 773 (120–31,820) < 0.001
–44) 1 (0–88) < 0.001
grafting, AVR – aortic valve replacement, CPB – cardiopulmonary bypass, PRC –
Table 3 Comparison of minor and major complications, hospital and ICU admission, and operative mortality in
patients with either POAF or NSR following CABG/OPCAB±AVR in Iceland between 2002 and 2006
POAF (n = 326) NSR (n= 418) p-value
Any major complication 59 (25) 70 (18) 0.03
Deep wound infection/mediastinitis/endocarditis (%) 3 (0.9) 1 (0.2) 0.03
Perioperative myocardial infarction (%) 48 (15) 53 (13) 0.34
Stroke (%) 7 (2.1) 6 (1.4) 0.23
Acute kidney injury requiring dialysis (%) 7 (2) 4 (0.9) 0.11
Sternum dehiscence (%) 15 (5) 3 (0.7) 0.24
Multiple organ failure/ARDS (%) 25 (8) 1 (0.2) < 0.001
Reoperation (%) 14 (4) 20 (5) 0.88
Pneumonia (%) 34 (10) 16 (4) < 0.001
Superficial wound infection (%) 31 (10) 36 (9) 0.66
Urinary tract infection (%) 26 (8) 11 (3) 0.002
Total hospital stay in days, mean (range) 15 (1–110) 10 (1–47) < 0.001
Stay in ICU in days, mean (range) 3 (1–13) 1.4 (1–41) < 0.001
Operative mortality, <30 days (%) 15 (5) 3 (0.7) 0.001
Table 4 A finalized logistic regression model of
independent risk factors for development of POAF
following CABG/OPCAB±AVR in Iceland between 2002
and 2006
Odds ratio 95% CI p-value
Aortic valve replacement 4.36 2.68–7.07 < 0.001
Chronic heart failure 1.81 1.10–2.99 < 0.001
EuroSCORE (per point) 1.10 1.03–1.17 < 0.001
Age (per year) 1.05 1.03–1.07 < 0.001
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blockers between groups but statin use was less common
in the POAF group (63% vs. 76%, p < 0.001).
Operative factors are compared in Table 2. In CABG
patients, the average cardiopulmonary bypass (CPB)
time was 15 min longer and aortic cross-clamp time was
on average 9 min longer in the POAF group. There was
a slight increase in postoperative bleeding, and POAF
patients also received more units of PRC.
Table 3 lists postoperative complications. A higher
ratio of minor infections (pneumonia, superficial
wound infections, and urinary tract infections) was
seen in patients with POAF and rates of major infec-
tions (endocarditis and mediastinitis) were more than
fourfold higher (0.9% vs. 0.2%, p = 0.03). Rates of post-
operative myocardial infarction, stroke, and renal failure
requiring dialysis were not significantly higher in the
POAF group but pleural effusion necessitating chest tube
drainage was more common in the POAF group. This
was also the case for sternum dehiscence (5% vs. 0.7%,
p = 0.001) and multiple organ failure or ARDS (8% vs.
0.2%, p <0.001), but reoperation for bleeding was similar
(4% vs. 5%, p = 0.9).
Median length of hospital stay was almost five days
longer for patients with POAF, and length of stay in the
intensive care unit was more than double that for
patients in the NSR group. Operative mortality within
30 days was about seven times higher in patients diag-
nosed with POAF (5% vs. 0.7%, p = 0.001).
In the finalized multivariate logistic model, the stron-
gest independent risk factor for POAF was AVR surgery
(OR 4.36), followed by a history of chronic heart failure
(OR 1.81), EuroSCORE (OR 1.1), and advanced age (OR1.05) (Table 4). The area under the ROC curve for the
finalized model was 0.74. Addition of a transformed
value of the age (square root, second power, or the
natural logarithm) did not change the significance of
EuroSCORE (data not shown).
Using the independent risk factors for POAF, we
created a risk table that can be used to predict the
probability of POAF for patients without prior AF, using
preoperative information on operation type, patient age,
and standard EuroSCORE (Figure 1). For example, the
risk score predicts that a 50-year-old individual under-
going OPCAB operation with a EuroSCORE of 2 has a
17% risk of POAF, while a 75-year-old individual under-
going AVR with a EuroSCORE of 6 has an 82% likeli-
hood of POAF.
The long-term survival of POAF patients differed sig-
nificantly from that of NSR patients (p <0.001, log-rank
test) (Figure 2), one- and five-year survival being 92%
(95% CI: 89–95%) and 83% (95% CI: 79–87%) for
patients with POAF as compared to 98% (95% CI: 97–
99%) and 93% (95% CI: 90–95%) in patients with NSR,
respectively. The presence of POAF was associated with
Isolated CABG / OPCAB         
EuroSCORE 
Age 0 2 4 6 8 10    
50 14 17 20 24 29 34    <30% 
55 17 20 24 29 34 39    30-70%
60 20 24 29 34 39 44    >70% 
65 24 29 34 39 44 50    
70 29 34 39 45 50 56    
75 34 39 45 50 56 61    
80 39 45 50 56 61 67    
AVR ± CABG         
EuroSCORE 
Age 2 4 6 8 10     
50 47 53 58 64 69     
55 53 59 64 69 74     
60 59 64 69 74 78     
65 64 69 74 78 82     
70 69 74 78 82 85     
75 74 78 82 85 87     
80 78 82 85 88 90     
Figure 1 Probability table of POAF. A risk score to evaluate the probability of postoperative fibrillation following CABG/OPCAB or AVR + CABG
for patients without any prior history of atrial fibrillation, based on age and standardized EuroSCORE. Probability is reported in percentages.
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3.93, p <0.001), but the HR was reduced in the model
(HR 1.64) when corrected for AVR, acute operation,
age, and EuroSCORE (Table 4).Figure 2 Survival of patients with POAF and NSR. A Kaplan-
Meyer survival curve of patients with POAF and NSR following
CABG/OPCAB, AVR, or CABG/OPCAB+AVR surgery in Iceland
between 2002 and 2006.Discussion
Following cardiac surgery in Iceland POAF was found to
be common, or 44%. This is a higher rate than found in
most other retrospective studies, where it has usually
ranged between 20% and 30% [10,21,22]. The reasons
for this are not entirely clear. One possible explanation
might be the extensive degree of electrocardiographic
monitoring that is performed at our institution relative
to that done in other studies, i.e. six days of constant tel-
emetry in all patients. As Aranki et al. have shown, 70%
of POAF occurrence is clustered around the first four
postoperative days, 94% being diagnosed in the first
6 days and only 6% more than a week after surgery [5].
Another possible explanation is the lack of systematic
use of prophylactic treatment for AF before open-heart
surgery at our hospital. Amiodarone therapy was rarely
used, and only 20% and 65% of the study patients, re-
spectively, were taking calcium channel blockers and
beta-blockers in the immediate postoperative phase. Fur-
thermore, a recent prospective study on the use of
omega-3 fatty acids for prevention of POAF in Iceland
has led to a couple of interesting observations in this
regard. Icelanders have a relatively high baseline levels
of omega-3 fatty acids in plasma phospholipids and this
particular study demonstrated that higher levels of
these fatty acids may actually increase the risk of POAF,
contrary to what was previously believed [23].
POAF was more often seen in females and in older
patients, especially those with a history of chronic heartfailure [5,24]. Furthermore, the higher EuroSCORE and
lower EF in the POAF group probably reflect comorbid-
ities that further facilitate the development of POAF. As
described in previous studies, the POAF rate was higher
in patients who underwent AVR or AVR in combination
with surgical revascularization. The nature of AVR sur-
gery may cause structural conduction disturbances and
more extensive tissue injury, which might increase the
risk of arrhythmias [10].
As in the meta-analysis of Møller et al. our univariate
analysis showed that patients who underwent OPCAB
were less likely to develop POAF than were CABG
patients [25]. This may be attributed to the systemic
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turn been shown to have a pro-fibrillatory effect [24,26].
After surgery, POAF patients received significantly
more transfusions of PRC, even though bleeding was
only slightly increased. A possible explanation for this is
that patients with POAF were believed to be more sen-
sitive to anaemia and loss of cardiac output following
surgery. It should, however, be emphasized that time-
line and causality were not clear in the study; therefore,
it might also be deduced that blood transfusions were
pro-fibrillatory in our patients, as shown in previous
studies [27].
In the univariate analysis, patients taking statins were
less likely to develop POAF. The potential benefit of
statin use preoperatively has been extensively researched
in patients undergoing cardiac surgery. The effects of
statins are still not clear, but randomized trials have
shown that they reduce the incidence of POAF follow-
ing elective cardiac surgery [28].
A number of previous studies have shown an advantage
of prophylactic therapy for POAF [29], but owing to
their possible negative inotropic effects and a lack of
consensus on clinical guidelines, their use has not been
universal. Furthermore, patients taking anti-arrhythmic
medications before surgery often go days without these
drugs postoperatively, due to their potentially negative
affects on hemodynamic stability in the early postopera-
tive period, which might further compound the risk of
arrhythmias during this period.
The main factors associated with an increased risk of
POAF were age, the complexity of the procedure, a his-
tory of heart failure, and low EF in addition to a higher
EuroSCORE—all factors that have been described in pre-
vious studies. This information was used to construct a
likelihood table for the development POAF, based on
age, operation type, and EuroSCORE (Figure 1). One of
the main strengths of our model is the complete dataset
that was available for its construction as well as its
simplicity, making it a feasible tool for use in clinical
practice. The main drawback was the observational de-
sign of our study and the low number of study patients,
even though incidence was higher than in most previous
studies, possibly due to higher pick-up rates. Using the
entire population to create the risk model was consid-
ered necessary to obtain sufficient power. There is a
possibility of overfitting—that the model describes the
risk in the population studied adequately but fails to
predict the risk in other patient cohorts. The model
would be improved by testing out its prediction cap-
abilities with an Icelandic validation cohort, ideally in
a prospective manner. We believe that a risk score
would help to identify patients who might be candi-
dates for prophylactic therapy or close electrocardio-
graphic monitoring.Patients with POAF were more likely to be diagnosed
with minor complications and any of the major compli-
cations, although not all of the individual major compli-
cations were significantly more frequent (i.e. stroke, MI,
AKI requiring dialysis, and sternum dehiscence). POAF
patients also had longer total length of hospital stay, and
their stay in ICU was more than doubled. This agrees
with the results of previous studies [30].
Postoperative (< 30-day) mortality was 5% in patients
who were diagnosed with POAF, as compared to 0.7% in
patients with NSR. The difference in survival is also
reflected in long-term survival, 5-year survival being
83% for POAF patients and 93% for NSR patients.
This is the first nationwide study of the incidence of
POAF following coronary artery and/or AVR surgery.
Other strengths of the study were that the patients were
found using two separate registries and the phenotype of
POAF was well defined, with comprehensive arrhythmia
surveillance of longer duration than in most other stud-
ies. All patients were operated on and treated for POAF
at a single centre, and they were therefore less likely to
be affected by bias due to tertiary referral. Furthermore,
none of the patients were lost to follow-up. The weak-
ness of the study was its non-randomized nature and the
inability to infer causality.Conclusion
In summary, this study shows a high incidence of
POAF following cardiac surgery. This may in part be
explained by a high pick-up rate, but other factors
could play a role. In light of the increased short- and
long-term risks of patients who develop POAF, it is
of particular importance to consider ways to reduce
the burden of this arrhythmia. Hopefully, a careful
preoperative risk profiling of patients who are particu-
larly likely to experience POAF can aid in selecting
patients who are eligible for prophylactic treatment and
increased monitoring. To that end, we constructed a
thorough risk model that, given further research,
might prove suitable in determination of the feasibil-
ity of prophylactic therapy.
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